Energenesis Biomedical CO.,LTD. (TPE:6657)
Taiwan · Delayed Price · Currency is TWD 29.40
-0.85 (-2.81%)
Jul 30, 2026, 1:30 PM CST
TPE:6657 Market Cap
TPE:6657 has a market cap or net worth of 2.66 billion as of July 29, 2026. Its market cap has decreased by -52.01% in one year.
Market Cap
2.66B
Enterprise Value
1.90B
Revenue
7.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
29.40
ChartMarket Cap Chart
Since August 8, 2018, TPE:6657's market cap has increased from 1.02B to 2.66B, an increase of 159.94%. That is a compound annual growth rate of 12.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 2.66B | -30.25% |
| Dec 31, 2025 | 3.81B | -1.55% |
| Dec 31, 2024 | 3.87B | -15.67% |
| Dec 29, 2023 | 4.59B | 60.69% |
| Dec 30, 2022 | 2.86B | -4.64% |
| Dec 30, 2021 | 3.00B | 2.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 8, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sagittarius Life Science | 3.36B |
| SYN-TECH Chem. & Pharm. | 3.22B |
| Apex Biotechnology | 3.22B |
| Shine-On BioMedical | 3.14B |
| 3D Global Biotech | 3.07B |
| Great Novel Therapeutics Biotech & Medicals | 3.07B |
| BioGend Therapeutics | 2.98B |
| Intech Biopharm | 2.83B |